BACKGROUND: Mitochondrial DNA (mtDNA) copy number in peripheral blood has been found to be associated with risk of developing several cancers. However, data on pancreatic ductal adenocarcinoma (PDAC) are very limited. METHODS: To further our knowledge on this topic, we measured relative mtDNA copy number by a quantitative real-time PCR assay in peripheral leukocyte samples of 476 PDAC cases and 357 controls nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. RESULTS: We observed lower mtDNA copy number with advancing age (P = 6.54 × 10-5) and with a high body mass index (BMI) level (P = 0.004) and no association with sex, smoking behavior, and alcohol consumption. We found an association between increased mtDNA copy number and decreased risk of developing PDAC with an odds ratios (OR) of 0.35 [95% confidence interval (CI), 0.16-0.79; P = 0.01] when comparing the fifth quintile with the first using an unconditional logistic regression and an OR of 0.19 (95% CI, 0.07-0.52; P = 0.001) with a conditional analysis. Analyses stratified by BMI showed an association between high mtDNA copy number and decreased risk in the stratum of normal weight, consistent with the main analyses. CONCLUSIONS: Our results suggest a protective effect of a higher number of mitochondria, measured in peripheral blood leukocytes, on PDAC risk. IMPACT: Our findings highlight the importance of understanding the mitochondrial biology in pancreatic cancer.

Mitochondrial DNA copy number variation and pancreatic cancer risk in the prospective EPIC cohort / M. Gentiluomo, V.A. Katzke, R. Kaaks, A. Tjonneland, G. Severi, V. Perduca, M.-. Boutron-Ruault, E. Weiderpass, P. Ferrari, T. Johnson, B.M. Schulze, M. Bergmann, A. Trichopoulou, A. Karakatsani, C. La Vecchia, D. Palli, S. Grioni, S. Panico, R. Tumino, C. Sacerdote, B. Bueno-de-Mesquita, R. Vermeulen, T.M. Sandanger, J.R. Quirós, M. Rodríguez-Barranco, P. Amiano, S. Colorado-Yohar, E. Ardanaz, M. Sund, K.-. Khaw, N.J. Wareham, J.A. Schmidt, P. Jakszyn, L. Morelli, F. Canzian, D. Campa. - In: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. - ISSN 1055-9965. - 29:3(2020 Mar 01), pp. 681-686. [10.1158/1055-9965.EPI-19-0868]

Mitochondrial DNA copy number variation and pancreatic cancer risk in the prospective EPIC cohort

C. La Vecchia;
2020

Abstract

BACKGROUND: Mitochondrial DNA (mtDNA) copy number in peripheral blood has been found to be associated with risk of developing several cancers. However, data on pancreatic ductal adenocarcinoma (PDAC) are very limited. METHODS: To further our knowledge on this topic, we measured relative mtDNA copy number by a quantitative real-time PCR assay in peripheral leukocyte samples of 476 PDAC cases and 357 controls nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. RESULTS: We observed lower mtDNA copy number with advancing age (P = 6.54 × 10-5) and with a high body mass index (BMI) level (P = 0.004) and no association with sex, smoking behavior, and alcohol consumption. We found an association between increased mtDNA copy number and decreased risk of developing PDAC with an odds ratios (OR) of 0.35 [95% confidence interval (CI), 0.16-0.79; P = 0.01] when comparing the fifth quintile with the first using an unconditional logistic regression and an OR of 0.19 (95% CI, 0.07-0.52; P = 0.001) with a conditional analysis. Analyses stratified by BMI showed an association between high mtDNA copy number and decreased risk in the stratum of normal weight, consistent with the main analyses. CONCLUSIONS: Our results suggest a protective effect of a higher number of mitochondria, measured in peripheral blood leukocytes, on PDAC risk. IMPACT: Our findings highlight the importance of understanding the mitochondrial biology in pancreatic cancer.
Pancreatic cancer; mitochondrial copy number; mtDNA copy number, cancer risk, prospective cohort, leukocyte
Settore MED/01 - Statistica Medica
1-mar-2020
13-gen-2020
Article (author)
File in questo prodotto:
File Dimensione Formato  
Mithocondrial DNA pancreas_ Gentiluomo.pdf

Open Access dal 02/03/2021

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 335.66 kB
Formato Adobe PDF
335.66 kB Adobe PDF Visualizza/Apri
681.full.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 315.68 kB
Formato Adobe PDF
315.68 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/705231
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 15
social impact